docetaxel anhydrous has been researched along with naftopidil in 1 studies
| Studies (docetaxel anhydrous) | Trials (docetaxel anhydrous) | Recent Studies (post-2010) (docetaxel anhydrous) | Studies (naftopidil) | Trials (naftopidil) | Recent Studies (post-2010) (naftopidil) |
|---|---|---|---|---|---|
| 12,110 | 3,216 | 6,920 | 233 | 58 | 124 |
| Protein | Taxonomy | docetaxel anhydrous (IC50) | naftopidil (IC50) |
|---|---|---|---|
| Bile salt export pump | Homo sapiens (human) | 10 | |
| Alpha-1D adrenergic receptor | Homo sapiens (human) | 0.0552 | |
| Alpha-1A adrenergic receptor | Homo sapiens (human) | 0.555 | |
| Alpha-1B adrenergic receptor | Homo sapiens (human) | 0.634 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Arima, K; Ishii, K; Kajiwara, S; Kanda, H; Kato, M; Matsuoka, I; Miki, M; Sasaki, T; Shiraishi, T; Sugimura, Y | 1 |
1 other study(ies) available for docetaxel anhydrous and naftopidil
| Article | Year |
|---|---|
Additive naftopidil treatment synergizes docetaxel-induced apoptosis in human prostate cancer cells.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Cell Growth Processes; Cell Line, Tumor; Docetaxel; Drug Synergism; Humans; Male; Mice; Mice, Nude; Naphthalenes; Piperazines; Prostatic Neoplasms; Prostatic Neoplasms, Castration-Resistant; Random Allocation; Taxoids; Xenograft Model Antitumor Assays | 2018 |